| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.4M | +28.2% |
| Cost of Revenue | $4.2M | +109.6% |
| R&D Expense | $8.0M | +22.3% |
| SG&A Expense | $30.1M | +31.5% |
| Operating Income | -$36.9M | -35.6% |
| Income Tax | $800 | -20.0% |
| Net Income | -$24.0M | +10.9% |
| EPS (Basic) | -$1.19 | +27.4% |
| EPS (Diluted) | -$1.19 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.8M | -51.3% |
| Accounts Receivable | $1.1M | -40.5% |
| Inventory | $11.6M | +3.9% |
| Current Assets | $31.8M | -31.9% |
| Total Assets | $41.2M | -57.3% |
| Current Liabilities | $7.9M | -16.7% |
| Total Liabilities | $14.0M | -2.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.1M | -16.7% |
| Capital Expenditures | $438K | +60.4% |
| Investing Cash Flow | -$1.4M | -441.7% |
| Financing Cash Flow | $19.1M | -68.1% |
| Free Cash Flow | -$34.5M | -17.1% |
| +27.4% |
| Stockholders' Equity |
| $27.2M |
| -65.9% |